# Efficacy and Safety of Spironolactone in Pediatric Hemodialysis Patients With Anemia.

> **NCT07715318** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Ain Shams University** · enrollment: 40 (estimated)

## Conditions studied

- Anemia

## Interventions

- **DRUG:** Spironolactone (drug)
- **DRUG:** Iron Supplement
- **DRUG:** Erythropoietin stimulating agent

## Key facts

- **NCT ID:** NCT07715318
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-12-01
- **Primary completion:** 2027-12-01
- **Final completion:** 2028-03-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07715318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07715318, "Efficacy and Safety of Spironolactone in Pediatric Hemodialysis Patients With Anemia.". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07715318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*